Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/37796
Title: THE EFFICACY and SAFETY of SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB in COMBINATION WITH TRADITIONAL DMARDS in PATIENTS WITH RA AT WEEK 97 (SUMMACTA)
Authors: Burmester, G.
Rubbert-Roth, A.
Cantagrel, A.
Hall, S.
Leszczynski, P.
Pollak, Daniel Feldman [UNIFESP]
Rangaraj, M. J.
Roane, G.
Ludivico, C.
Mysler, E.
Bennett, M. J.
Rowell, L.
Bao, M.
Free Univ Berlin
Humboldt Univ
Klinikum Univ Koln
Ctr Hosp Univ Toulouse
Cabrini Med Ctr
Poznan Med Univ
Universidade Federal de São Paulo (UNIFESP)
Arthrit & Diabet Clin Inc
Rheumatol Associates South Carolina
East Penn Rheumatol Associates
Org Med Invest
Roche Prod Ltd
Genentech Inc
Issue Date: 1-Jun-2014
Publisher: Bmj Publishing Group
Citation: Annals of the Rheumatic Diseases. London: Bmj Publishing Group, v. 73, p. 499-500, 2014.
URI: http://repositorio.unifesp.br/handle/11600/37796
ISSN: 0003-4967
Other Identifiers: http://dx.doi.org/10.1136/annrheumdis-2014-eular.1347
Appears in Collections:Em verificação - Geral

Files in This Item:
File Description SizeFormat 
WOS000346919802420.pdf877.32 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.